SecBot SecBot
144 ·Filed Jun 9, 2026

AXSM

Axsome Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizondays Processed5mo ago SEC0001958244-26-000358
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The pre-planned 10b5-1 sale reduces signaling concerns, but continued insider selling warrants monitoring for potential overhang. The strong analyst consensus (93% bullish) and historical performance may offset bearish sentiment.

DirectionNeutral
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$246.34
T+0 close · Jun 9, 2026 · via day close
Latest settled
−15.42%
T+60 · $208.35
Vs SPY
−22.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 10 $246.34entry
  2. T+1 · 5mo ago +3.02%α +1.32% · $253.77
  3. T+5 · 5mo ago +2.26%α −1.17% · $251.91
  4. T+20 · 4mo ago +1.06%α −2.56% · $248.95
  5. T+60 · 2mo ago −15.42%α −22.00% · $208.35
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Herriot Tabuteau files Form 144 to sell 49,670 shares of Axsome Therapeutics (~$12.2M) under a 10b5-1 plan dated 3/10/2026. The sale is pre-planned but adds to recent insider selling activity.

Key Facts

  • CEO Herriot Tabuteau files to sell 49,670 shares (~$12.2M) under a 10b5-1 plan.
  • The 10b5-1 plan was established on 3/10/2026, indicating pre-planned sale.
  • Recent insider selling (30d) totals $19.9M, with this filing adding to the trend.

Financial Impact

CEO selling ~$12.2M in shares; secondary market sale, no dilution.

Risk Factors

  • Insider selling pattern could indicate management caution.
  • Potential overhang from planned sales.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001958244-26-000358
Document: 0001958244-26-000358-index.html0001958244-26-000358
Document: 0001958244-26-000358.txt0001958244-26-000358

Track record

26 reports on AXSM

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.

Filters
  1. Nov 2, 202614d ago 8-K Bullish 6/10 No price data
  2. Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
  3. Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
  4. Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
  5. Aug 10, 202614w ago 8-K Neutral 6/10 No price data
  6. Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
  7. Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
  8. Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
  9. Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
  10. Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens in 7h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 9, 2026